Scientists at the University of Texas A&M have identified a variant of the new coronavirus that is potentially resistant to antibodies, the university said in a statement. The strain, BV-1, was found in an individual who reported mild symptoms of COVID-19. laboratory tests, research has shown that “several neutralizing antibodies are ineffective in controlling other variants with the same genetic markers as BV-1,” the university said. “We do not currently know the full significance of this variant, but it has a combination of mutations. similar to other concerns that can be reported internationally, “said Chief Virologist Ben Neuman, Global Health Research Complex (GHRC). This variant combines separate genetic markers associated with rapid spread, severe disease and high resistance to neutralizing antibodies. “We have not detected any cases of this variant,” he added. “We have not grown or tested this virus in any way. This announcement is based exclusively on laboratory genetic sequence analysis.” The genetic makeup of BV-1 is The original variant was found in the United Kingdom in September, with over 30 countries identifying cases in the United Kingdom. l their borders, after the new strain reached its title just before Christmas.
cnxps.cmd.push (function () {cnxps ({playerId: ’36af7c51-0caf-4741-9824-2c941fc6c17b’}). render (‘4c4d856e0e6f4e3d808bbc1715e132f6’);});
if (window.location.pathname.indexOf (“656089”)! = -1) {console.log (“hedva connatix”); function.getElementsByClassName (“divConnatix”)[0].style.display = “none”;}The British variant is apparently more transmissible than the original viral strain, according to research conducted by Imperial College London in collaboration with the World Health Organization (WHO) and other educational institutions in the UK. a student at Texas A&M. School officials were alerted to the positive test after a saliva sample was taken from the student, as part of the school’s testing efforts, indicated a positive coronavirus infection. In light of the discovery, researchers at Texas A&M sent their findings to both the Centers for Disease Control and Prevention (CDC) in Atlanta and GISAID, which is a science initiative in Munich. sharing information about the new coronavirus to scientists around the world. Texas A&M researchers plan to dive further into their research to determine if there are still variants present in the student population, including examining possible asymptomatic cases of the disease around campus. it helps provide an early warning system for new variants, ”said Neuman. Although we may not yet understand the full significance of BV-1, the variant highlights the continuing need for rigorous surveillance and genomic testing, including among young adults with no or only mild symptoms.